Skip to main content

Table 5 Expected distribution (as percentages) of 7-point ordinal scale at day 14 for placebo/standard of care group where “best”, “expected” and “worst” case is from the patient’s perspective

From: Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

Categories

Best

Expected

Worst

Not hospitalised, no limitations on activities

16.0

0.1

0.1

Not hospitalised, some limitation on activities

28.6

31.0

19.4

Hospitalised, not requiring supplemental oxygen

32.0

34.0

30.0

Hospitalised, requiring supplemental oxygen

13.0

15.5

20.0

Hospitalised, requiring non-invasive mechanical ventilation or high flow nasal cannula therapy

2.4

4.7

7.0

Hospitalised, requiring invasive mechanical ventilation ± additional organ support

2.0

4.0

5.5

Death

6.0

10.7

18.0